Taysha Gene Therapies shares owned by Vanguard Group
Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Taysha Gene Therapies
Tip: Access up to 7 years of quarterly data
All positions including Taysha Gene Therapies held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taysha Gene Therapies by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $11M | 6.2M | 1.77 |
| 2023-09-30 | $17M | 5.3M | 3.16 |
| 2023-06-30 | $1.1M | 1.6M | 0.66 |
| 2023-03-31 | $1.3M | 1.6M | 0.80 |
| 2022-12-31 | $3.5M | 1.6M | 2.26 |
| 2022-06-30 | $4.0M | 1.1M | 3.72 |
| 2022-03-31 | $6.6M | 1.0M | 6.52 |
| 2021-09-30 | $15M | 806k | 18.62 |
| 2021-06-30 | $13M | 629k | 21.20 |
| 2021-03-31 | $9.3M | 460k | 20.31 |
| 2020-12-31 | $12M | 465k | 26.53 |
| 2020-09-30 | $1.7M | 75k | 22.40 |